Details
August 4, 2020
12:00-1:00PM
XPOVIO® (selinexor) The first and only FDA-approved oral selective nuclear export inhibitor in relapsed refractory multiple myeloma (RRMM)
Hosted by Karyopharm
WEBINAR
XPOVIO® Prescribing Information
2020-08-04 2020-08-04 13:00:00 America/Detroit XPOVIO® (selinexor) The first and only FDA-approved oral selective nuclear export inhibitor in relapsed refractory multiple myeloma (RRMM) Event Information XPOVIO® Prescribing Information WEBINAR